Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-Week Multicenter, 2-Arm Regimen, Exploratory Study to Evaluate the Tolerability and Safety of Valsartan Administered Once Daily vs Daily, in Patients With Stable, Chronic Heart Failure (NYHA Class Ll-lll)

NCT00294086 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00294086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00294086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-Week Multicenter, 2-Arm Regimen, Exploratory Study to Evaluate the Tolerability and Safety of Valsartan Administered Once Daily vs Daily, in Patients With Stable, Chronic Heart Failure (NYHA Class Ll-lll)
Lead sponsor
Novartis
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2005
Completion date
January 31, 2007
Enrollment
160
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure